Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AZPN
Valuation Bad
0%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 21.78 2.32 1.91
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -69.74 -0.76 -0.45
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value < 0.005 201.72 201.72
Cash 59.35 2.80 1.75
Capex -81.53 -0.02 < 0.005
Free Cash Flow 370.65 2.16 0.46
Revenue 8.47 4.38 4.04
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -29.63 0.44 0.63
Operating Margin 63.77 -0.07 -0.19
ROA -92.70 < 0.005 < 0.005
ROE -92.74 < 0.005 < 0.005
ROIC -86.02 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AZPN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AZPN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AZPN is permitted for members.